Roche receives FDA Emergency Use Authorization for new semi-quantitative test to measure the level of SARS-CoV-2 antibodies

INDIANAPOLIS, Dec. 1, 2020 /PRNewswire/ -- Roche (SIX: RO, ROG;OTCQX: RHHBY) today announced that its Elecsys® Anti-SARS-CoV-2 S antibody test has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). The semi-quantitative serology (blood) test can be used to measure the level of antibodies in people who have been exposed to the SARS-CoV-2 virus.

CancerIQ officially launches lab network to increase awareness and accelerate adoption of genetic testing

CHICAGO, November 19, 2020 — CancerIQ, an enterprise precision health platform for cancer, has formed a network of trusted genetic labs to streamline and inform the genetic test ordering process. The CancerIQ Lab Network increases access to genetic testing and improves the experience for providers and genetic testing labs.

LabCorp is scheduled to present at the 2020 Evercore ISI 3rd Annual HealthCONx conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Nov. 25, 2020-- LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, today announced that members of the executive management team will participate in a virtual fireside chat at the 3rd Annual Evercore ISI HealthCONx Conference on Thursday, Dec. 3 at 1:50 p.m. ET.